Theranostic Role of Iron Oxide Nanoparticle for Treating Renal Anemia: Evidence of Efficacy and Significance by MRI, Histology and Biomarkers

(1) Background: Increasing attention has been given to applying nanosized iron oxide nanoparticles (IOPs) to treat iron deficiency anemia (IDA). Chronic kidney disease (CKD) patients who suffer from IDA often need long-term iron supplements. We aim to evaluate the safety and therapeutic effect of MP...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsiao, Jong-Kai, Chen, Chih-Lung, Hsieh, Wen-Yuan, Kuo, Ko-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301580/
https://www.ncbi.nlm.nih.gov/pubmed/37376162
http://dx.doi.org/10.3390/pharmaceutics15061714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301580/
https://www.ncbi.nlm.nih.gov/pubmed/37376162
http://dx.doi.org/10.3390/pharmaceutics15061714

Ejemplares similares